Oct 2, 2026 11:44AM
May 22, 2026 07:30AM
May 22, 2026 07:30AM
Feb 23, 2026 09:36AM
Jan 14, 2026 10:39AM
May 7, 2024 08:00AM
Jan 2, 2024 06:00AM ImmunityBio (IBRX) Announces $320M Investment by Oberland Capital
Jan 2, 2024 06:00AM
Aug 11, 2023 09:00PM
Aug 6, 2023 09:00PM
Jul 31, 2023 09:00PM
Jul 26, 2023 09:00PM
Feb 15, 2022 09:00AM
Feb 14, 2022 05:18PM ImmunityBio (IBRX) Announces Over 24 Months Median Duration of Complete Remission in Patients with BCG Unresponsive Bladder Cancer
Feb 14, 2022 05:17PM
Jan 19, 2022 05:23AM
Jan 18, 2022 06:00PM
Jan 12, 2022 08:32AM
Jan 12, 2022 08:30AM
Dec 20, 2021 09:00AM
Nov 8, 2021 04:11PM Amyris, Inc. Reports Third Quarter 2021 Financial Results
Nov 4, 2021 09:00AM
Oct 19, 2021 09:02AM
Oct 19, 2021 09:00AM
Oct 13, 2021 09:00AM
Oct 4, 2021 08:30AM
Sep 13, 2021 08:32AM
Sep 13, 2021 08:30AM ImmunityBio Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% Remainin
Sep 7, 2021 08:30AM
Sep 1, 2021 09:00AM
Aug 16, 2021 09:05AM
Aug 16, 2021 09:00AM
Jul 27, 2021 09:00AM
Jul 14, 2021 09:06AM
Jul 14, 2021 09:00AM ImmunityBio Announces Authorization to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against
Jun 28, 2021 09:00AM
Jun 23, 2021 04:05PM
Jun 15, 2021 07:06AM
Jun 15, 2021 07:00AM
Jun 10, 2021 09:08AM
Jun 10, 2021 09:00AM
May 25, 2021 09:03AM ImmunityBio (IBRX) Expands Trials of T-Cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South Africa
May 25, 2021 09:00AM
May 24, 2021 09:00AM
May 20, 2021 09:00AM
May 17, 2021 09:05AM
May 17, 2021 09:00AM
May 13, 2021 08:00AM
May 4, 2021 09:05AM ImmunityBio (IBRX) Announces 78% Complete Response Following Chemotherapy-Free Combination of IL-15 Superagonist Anktiva with Rituxan in Relapsed Non-Hodgkin Lymphoma Patients
May 4, 2021 09:00AM

1,199,252 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All